MyFinsight
Home
Compare
About
Recent SEC Filings
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
PPCB Cash Flow Sankey Diagram
Sankey diagram visualizing PPCB cash flow for the period
Proceeds from the sale of
common stock, net of...
$3,314,458
Proceeds from exercise of
series c warrants
$3,000,000
Proceeds from issuance of
the initial...
$950,099
Proceeds from
convertible promissory...
$100,000
(-55.06%↓ Y/Y)
Proceeds from loans
payable - related...
$78,249
(-77.23%↓ Y/Y)
Proceeds from note
payable
$75,000
(-76.56%↓ Y/Y)
Net cash provided by
financing activities
$6,457,298
(1215.79%↑ Y/Y)
Effect of exchange rate
changes on cash
$50,188
(153.06%↑ Y/Y)
Canceled cashflow
$1,060,508
Net increase
(decrease) in cash
$819,918
(9213.24%↑ Y/Y)
Canceled cashflow
$5,687,568
Repayment of notes
$671,777
(447.10%↑ Y/Y)
Repayment of convertible
notes
$203,350
(2441.88%↑ Y/Y)
Repayment of loans payable
- related party
$185,381
Amortization of prepaid stock
based expenses
$8,498,492
(83.90%↑ Y/Y)
Issuance of common stock
for services
$4,993,748
(-90.27%↓ Y/Y)
Amortization of debt
discounts
$210,076
(-30.80%↓ Y/Y)
Change in fair value of
warrant liability
$99,695
Stock based
settlement
$75,000
Employee benefit
liability
$51,476
(28.10%↑ Y/Y)
Accrued interest
$44,545
(-82.54%↓ Y/Y)
Accretion of put premium
-$37,450
Amortization of right-of-use
assets
$21,706
(7.52%↑ Y/Y)
Non-cash interest
expense
$6,781
(22.87%↑ Y/Y)
Depreciation expense
$997
Net cash used in
operating activities
-$5,682,635
(-1302.54%↓ Y/Y)
Net cash used in
investing activities
-$4,933
Canceled cashflow
$14,039,966
Net loss
-$18,862,710
(67.99%↑ Y/Y)
Purchase of equipment
$4,933
Accrued expenses and
other payables
-$401,049
(-159.16%↓ Y/Y)
Accounts payable
-$183,012
(-197.49%↓ Y/Y)
Loss (gain) on
extinguishment of debt, net
$133,071
(115.28%↑ Y/Y)
Prepaid expenses
$41,121
(3081.94%↑ Y/Y)
Other current assets
$33,471
Foreign currency
transaction loss (gain)
$32,152
(136.03%↑ Y/Y)
Operating lease liability
-$14,189
(34.68%↑ Y/Y)
Change in fair value of
derivative liabilities
$13,709
(-93.55%↓ Y/Y)
Gst receivable
$8,117
(237.51%↑ Y/Y)
Back
Back
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)
Cash Flow
Annual Cash Flow Statement for the year ending in 2026-06-30
source: myfinsight.com